Health Industry News
South Africa’s leading independent health communications agency joins GLOBALHealthPR
World’s largest independent healthcare communications network strengthens market-leading offering across Asia Pacific, North America, South America, Europe & Africa GLOBALHealthPR®, the largest independent health and science communications agency partnership worldwide, represented exclusively by VIVA! Communications in Australia, today welcomed Johannesburg-based F/NE to its rapidly expanding global network. Founded more than 18 years ago, F/NE has…
Read MoreNational Education Initiative launched to support youth mental health
Leading Australian mental health organisations have come together today to announce the launch of a new National Education Initiative transforming the country’s approach to youth care. From August 2018, beyondblue, headspace, and Early Childhood Australia will attempt to provide an end-to-end mental health framework in schools. The National Education Initiative has attracted AUD$45m in funding…
Read MoreResearchers identify potential privacy breach with patient records
Researchers have been able to identify individuals in anonymous government healthcare data, potentially exposing private information from data published by the federal Department of Health in August 2016. According to ABC Online story, the changes were part of a move towards “open data” with the historical information including medical and pharmaceutical bills of about 10…
Read MoreDifference between physiotherapy and chiropractic
The majority of people will experience some kind of neck pain, back pain or other musculoskeletal injury at some point throughout their lives. Whether this be a sporting injury, as a result of a car accident or simply from general wear and tear of the joints and muscles in our body, most people who seek…
Read MoreAustralian developed, first-in-class rheumatoid arthritis medication secures green-light for human trials in Brisbane
Australia’s first in-human study of a first-in-class rheumatoid arthritis immunotherapy treatment developed by University of Queensland researchers was launched on November 14, 2017. The Phase 1, double-blind, placebo-controlled study currently underway at Brisbane’s Princess Alexandra Hospital, will consider both single-ascending dose, and multi-dose protocols to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous (under…
Read More